semaglutide long term safety GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Abstract 4134308: Re-evaluating the safety

(PubMed) Izzo AA, Ernst E

This narrative review covers the top-selling nutraceutical, collagen, along with the antioxidants, curcumin and glutathione, in women aged 30 to over 65 years regarding their effectiveness in enhancing dermal health parameters

Many patients report difficulty eating enough to hit their protein targets, which is where choosing the right foods becomes critical

Sesame said the GLP-1s can be between $950 and $1,600 a month, which may not be covered by insurance

By end user, the homecare settings segment dominated the market with a share of 64% in 2025 and is expected to grow at the fastest CAGR of 15.1% in the coming years

Cell 75 , 807822.e8 (2019)